Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5203584
Max Phase: Preclinical
Molecular Formula: C41H57N13O10S2
Molecular Weight: 956.12
Associated Items:
ID: ALA5203584
Max Phase: Preclinical
Molecular Formula: C41H57N13O10S2
Molecular Weight: 956.12
Associated Items:
Canonical SMILES: C[C@@H](O)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSCc2cccc(n2)CSC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC1=O
Standard InChI: InChI=1S/C41H57N13O10S2/c1-21(55)34-39(62)51-27(10-5-13-46-41(44)45)35(58)50-28(11-12-32(43)56)36(59)52-29(14-22-16-47-26-9-3-2-8-25(22)26)37(60)53-31(40(63)64)20-66-18-24-7-4-6-23(48-24)17-65-19-30(38(61)54-34)49-33(57)15-42/h2-4,6-9,16,21,27-31,34,47,55H,5,10-15,17-20,42H2,1H3,(H2,43,56)(H,49,57)(H,50,58)(H,51,62)(H,52,59)(H,53,60)(H,54,61)(H,63,64)(H4,44,45,46)/t21-,27+,28+,29+,30+,31+,34+/m1/s1
Standard InChI Key: JXNLDHOMBNHQLT-INDSUJOGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 956.12 | Molecular Weight (Monoisotopic): 955.3793 | AlogP: -2.85 | #Rotatable Bonds: 13 |
Polar Surface Area: 391.82 | Molecular Species: ZWITTERION | HBA: 14 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.64 | CX Basic pKa: 11.61 | CX LogP: -6.31 | CX LogD: -6.86 |
Aromatic Rings: 3 | Heavy Atoms: 66 | QED Weighted: 0.05 | Np Likeness Score: 0.60 |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):